The biotech is bulking up with a new acquisition.
Compare BTX Stock to Peers
|Symbol||Last Price||Market Cap||% Δ 1 Yr||% Δ 5 Yr|
Brooklyn ImmunoTherapeutics, Inc.
News & Analysis: Brooklyn ImmunoTherapeutics, Inc.
This clinical-stage biotech was one of April's brightest stars.
An unknown biotech has turned its early investors into millionaires over the past month. Can it continue its momentum?